Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker MIRM
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Nov 12, 2026 | Laura Brege Director | MIRM Mirum Pharmaceuticals, Inc. | 14,167 | $1.3M | — | Nov 11, 2026 | Form 4 ↗ 1 day later · 14,167 shares | Form 144 ↗ |
| Nov 4, 2026 | Christopher Peetz Officer, Director | MIRM Mirum Pharmaceuticals, Inc. | 20,000 | $1.8M | 10b5-1 | Nov 4, 2026 | Form 4 ↗ same day · 20,000 shares | Form 144 ↗ |
| Nov 4, 2026 | Joanne Quan Former Officer | MIRM Mirum Pharmaceuticals, Inc. | 14,684 | $1.4M | — | Nov 4, 2026 | — | Form 144 ↗ |
| Sep 15, 2026 | Eric Bjerkholt Officer | MIRM Mirum Pharmaceuticals, Inc. | 9,943 | $978.1K | — | Sep 14, 2026 | Form 4 ↗ same day · 9,943 shares | Form 144 ↗ |
| Sep 2, 2026 | Jolanda Marie Howe Officer | MIRM Mirum Pharmaceuticals, Inc. | 658 | $65.8K | 10b5-1 | Sep 2, 2026 | Form 4 ↗ 1 day later · 658 shares | Form 144 ↗ |
| Sep 1, 2026 | Christopher Peetz Officer, Director | MIRM Mirum Pharmaceuticals, Inc. | 30,000 | $3.0M | 10b5-1 | Sep 1, 2026 | Form 4 ↗ 2 days later · 30,000 shares | Form 144 ↗ |
| Aug 18, 2026 | Jolanda Marie Howe Officer | MIRM Mirum Pharmaceuticals, Inc. | 40,000 | $4.0M | — | Aug 18, 2026 | Form 4 ↗ 1 day later · 40,000 shares | Form 144 ↗ |
| Aug 11, 2026 | Eric Bjerkholt Officer | MIRM Mirum Pharmaceuticals, Inc. | 6,001 | $599.5K | — | Aug 11, 2026 | Form 4 ↗ 1 day later · 6,001 shares | Form 144 ↗ |
| Aug 10, 2026 | Christopher Peetz Officer, Director | MIRM Mirum Pharmaceuticals, Inc. | 20,000 | $2.0M | 10b5-1 | Aug 10, 2026 | Form 4 ↗ 1 day later · 20,000 shares | Form 144 ↗ |
| Aug 3, 2026 | Jolanda Marie Howe Officer | MIRM Mirum Pharmaceuticals, Inc. | 1,840 | $193.7K | 10b5-1 | Aug 3, 2026 | Form 4 ↗ 2 days later · 1,840 shares | Form 144 ↗ |
| Jul 6, 2026 | Christopher Peetz Officer, Director | MIRM Mirum Pharmaceuticals, Inc. | 20,000 | $2.4M | 10b5-1 | Jul 6, 2026 | Form 4 ↗ 2 days later · 20,000 shares | Form 144 ↗ |
| Jul 6, 2026 | Eric Bjerkholt Officer | MIRM Mirum Pharmaceuticals, Inc. | 5,000 | $611.3K | 10b5-1 | Jul 6, 2026 | Form 4 ↗ 2 days later · 5,000 shares | Form 144 ↗ |
| Jul 1, 2026 | Jolanda Marie Howe Officer | MIRM Mirum Pharmaceuticals, Inc. | 2,721 | $326.5K | 10b5-1 | Jul 1, 2026 | Form 4 ↗ 1 day later · 2,721 shares | Form 144 ↗ |
| Jun 17, 2026 | Jolanda Marie Howe Officer | MIRM Mirum Pharmaceuticals, Inc. | 2,594 | $264.5K | 10b5-1 | Jun 17, 2026 | Form 4 ↗ 1 day later · 2,594 shares | Form 144 ↗ |
| Jun 8, 2026 | Eric Bjerkholt Officer | MIRM Mirum Pharmaceuticals, Inc. | 5,000 | $469.1K | 10b5-1 | Jun 8, 2026 | Form 4 ↗ 1 day later · 5,000 shares | Form 144 ↗ |
| Jun 1, 2026 | Christopher Peetz Officer, Director | MIRM Mirum Pharmaceuticals, Inc. | 30,000 | $2.9M | 10b5-1 | Jun 1, 2026 | Form 4 ↗ 1 day later · 30,000 shares | Form 144 ↗ |
| Jun 1, 2026 | Saira Ramasastry Director | MIRM Mirum Pharmaceuticals, Inc. | 3,977 | $397.7K | 10b5-1 | Jun 1, 2026 | Form 4 ↗ 1 day later · 3,977 shares | Form 144 ↗ |
| May 15, 2026 | Saira Ramasastry Director | MIRM Mirum Pharmaceuticals, Inc. | 2,000 | $218.9K | 10b5-1 | May 15, 2026 | Form 4 ↗ 3 days later · 2,000 shares | Form 144 ↗ |
| Apr 15, 2026 | Saira Ramasastry Director | MIRM Mirum Pharmaceuticals, Inc. | 2,000 | $193.8K | 10b5-1 | Apr 15, 2026 | Form 4 ↗ 1 day later · 2,000 shares | Form 144 ↗ |
| Mar 17, 2026 | Jolanda Howe Officer | MIRM Mirum Pharmaceuticals, Inc. | 4,732 | $438.4K | 10b5-1 | Mar 16, 2026 | Form 4 ↗ same day · 4,732 shares | Form 144 ↗ |
| Mar 17, 2026 | Joanne Quan Officer | MIRM Mirum Pharmaceuticals, Inc. | 7,287 | $675.1K | 10b5-1 | Mar 16, 2026 | Form 4 ↗ same day · 7,287 shares | Form 144 ↗ |
| Mar 17, 2026 | Peter Radovich Officer | MIRM Mirum Pharmaceuticals, Inc. | 16,515 | $1.5M | 10b5-1 | Mar 16, 2026 | Form 4 ↗ same day · 16,515 shares | Form 144 ↗ |
| Mar 17, 2026 | Christopher Peetz Officer, Director | MIRM Mirum Pharmaceuticals, Inc. | 40,985 | $3.8M | 10b5-1 | Mar 16, 2026 | Form 4 ↗ 77 days later · 30,000 shares | Form 144 ↗ |
| Mar 17, 2026 | Eric Bjerkholt Officer | MIRM Mirum Pharmaceuticals, Inc. | 7,287 | $675.1K | 10b5-1 | Mar 16, 2026 | Form 4 ↗ 84 days later · 5,000 shares | Form 144 ↗ |
| Mar 16, 2026 | Saira Ramasastry Director | MIRM Mirum Pharmaceuticals, Inc. | 2,000 | $181.5K | 10b5-1 | Mar 16, 2026 | Form 4 ↗ 1 day later · 2,000 shares | Form 144 ↗ |
| Feb 13, 2026 | Saira Ramasastry Director | MIRM Mirum Pharmaceuticals, Inc. | 2,000 | $204.2K | 10b5-1 | Feb 13, 2026 | Form 4 ↗ 4 days later · 2,000 shares | Form 144 ↗ |
| Feb 2, 2026 | Jolanda Howe Officer | MIRM Mirum Pharmaceuticals, Inc. | 968 | $100.5K | 10b5-1 | Feb 2, 2026 | Form 4 ↗ 1 day later · 968 shares | Form 144 ↗ |
| Feb 2, 2026 | Peter Radovich Officer | MIRM Mirum Pharmaceuticals, Inc. | 2,631 | $273.1K | 10b5-1 | Feb 2, 2026 | Form 4 ↗ 1 day later · 2,631 shares | Form 144 ↗ |
| Feb 2, 2026 | Christopher Peetz Officer, Director | MIRM Mirum Pharmaceuticals, Inc. | 9,108 | $945.4K | 10b5-1 | Feb 2, 2026 | Form 4 ↗ 1 day later · 9,108 shares | Form 144 ↗ |
| Jan 28, 2026 | Jolanda Howe Officer | MIRM Mirum Pharmaceuticals, Inc. | 842 | $81.6K | 10b5-1 | Jan 26, 2026 | Form 4 ↗ 6 days later · 968 shares | Form 144 ↗ |
| Jan 28, 2026 | Peter Radovich Officer | MIRM Mirum Pharmaceuticals, Inc. | 3,143 | $304.6K | 10b5-1 | Jan 26, 2026 | Form 4 ↗ 6 days later · 2,631 shares | Form 144 ↗ |
| Jan 28, 2026 | Christopher Peetz Officer, Director | MIRM Mirum Pharmaceuticals, Inc. | 6,831 | $662.1K | 10b5-1 | Jan 26, 2026 | Form 4 ↗ 6 days later · 9,108 shares | Form 144 ↗ |
| Jan 28, 2026 | Eric Bjerkholt Officer | MIRM Mirum Pharmaceuticals, Inc. | 1,053 | $102.1K | 10b5-1 | Jan 26, 2026 | Form 4 ↗ 48 days later · 7,287 shares | Form 144 ↗ |
| Jan 15, 2026 | Saira Ramasastry Director | MIRM Mirum Pharmaceuticals, Inc. | 2,000 | $182.0K | 10b5-1 | Jan 15, 2026 | Form 4 ↗ 1 day later · 2,000 shares | Form 144 ↗ |
| Dec 22, 2025 | Saira Ramasastry Director | MIRM Mirum Pharmaceuticals, Inc. | 5,000 | $400.0K | 10b5-1 | Dec 22, 2025 | Form 4 ↗ 1 day later · 5,000 shares | Form 144 ↗ |
| Dec 19, 2025 | Michael Grey Director | MIRM Mirum Pharmaceuticals, Inc. | 50,000 | $3.9M | 10b5-1 | Dec 19, 2025 | Form 4 ↗ 4 days later · 50,000 shares | Form 144 ↗ |
| Dec 18, 2025 | Saira Ramasastry Director | MIRM Mirum Pharmaceuticals, Inc. | 2,000 | $139.5K | 10b5-1 | Dec 18, 2025 | Form 4 ↗ 1 day later · 2,000 shares | Form 144 ↗ |
| Dec 1, 2025 | Michael Grey Director | MIRM Mirum Pharmaceuticals, Inc. | 50,000 | $3.7M | 10b5-1 | Dec 1, 2025 | Form 4 ↗ 1 day later · 50,000 shares | Form 144 ↗ |
| Nov 21, 2025 | Michael Grey Director | MIRM Mirum Pharmaceuticals, Inc. | 50,000 | $3.5M | 10b5-1 | Nov 21, 2025 | Form 4 ↗ 4 days later · 50,000 shares | Form 144 ↗ |
| Sep 11, 2025 | Laura Brege Director | MIRM Mirum Pharmaceuticals, Inc. | 17,000 | $1.3M | — | Sep 11, 2025 | Form 4 ↗ 1 day later · 17,000 shares | Form 144 ↗ |
| Sep 8, 2025 | Saira Ramasastry Director | MIRM Mirum Pharmaceuticals, Inc. | 17,000 | $1.3M | — | Sep 8, 2025 | Form 4 ↗ 2 days later · 17,000 shares | Form 144 ↗ |
| Aug 11, 2025 | Christopher Peetz Officer, Director | MIRM Mirum Pharmaceuticals, Inc. | 40,000 | $2.5M | 10b5-1 | Aug 11, 2025 | Form 4 ↗ 1 day later · 40,000 shares | Form 144 ↗ |
| Aug 7, 2025 | Jolanda Marie Howe Officer | MIRM Mirum Pharmaceuticals, Inc. | 10,000 | $580.0K | 10b5-1 | Aug 7, 2025 | Form 4 ↗ 1 day later · 10,000 shares | Form 144 ↗ |
| Aug 7, 2025 | Christopher Peetz Officer, Director | MIRM Mirum Pharmaceuticals, Inc. | 40,000 | $2.2M | 10b5-1 | Aug 7, 2025 | Form 4 ↗ 1 day later · 40,000 shares | Form 144 ↗ |
| Jul 3, 2025 | Jolanda Marie Howe Officer | MIRM Mirum Pharmaceuticals, Inc. | 477 | $23.4K | 10b5-1 | Jul 3, 2025 | Form 4 ↗ same day · 1,041 shares | Form 144 ↗ |
| Jun 11, 2025 | William C Fairey Director | MIRM Mirum Pharmaceuticals, Inc. | 3,203 | $155.1K | — | Jun 11, 2025 | Form 4 ↗ 2 days later · 3,203 shares | Form 144 ↗ |
| Jun 3, 2025 | Saira Ramasastry Director | MIRM Mirum Pharmaceuticals, Inc. | 2,500 | $114.4K | — | Jun 3, 2025 | Form 4 ↗ 1 day later · 8,203 shares | Form 144 ↗ |
| Jun 2, 2025 | Saira Ramasastry Director | MIRM Mirum Pharmaceuticals, Inc. | 5,703 | $263.5K | — | Jun 2, 2025 | Form 4 ↗ 2 days later · 8,203 shares | Form 144 ↗ |
| Mar 18, 2025 | Jolanda Marie Howe Officer | MIRM Mirum Pharmaceuticals, Inc. | 2,415 | $107.3K | 10b5-1 | Mar 18, 2025 | Form 4 ↗ 1 day later · 2,415 shares | Form 144 ↗ |
| Mar 17, 2025 | Jolanda Marie Howe Officer | MIRM Mirum Pharmaceuticals, Inc. | 54,706 | $2.4M | 10b5-1 | Mar 17, 2025 | Form 4 ↗ 1 day later · 57,606 shares | Form 144 ↗ |
The newest 50 items, most recent first. Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 7:20 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances